Citace podle APA (7th ed.)

Tourbah, A., Lebrun-Frenay, C., Edan, G., Clanet, M., Papeix, C., Vukusic, S., . . . Pelletier, J. (2016). MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study. Multiple sclerosis, 22(13), 1719. https://doi.org/10.1177/1352458516667568

Citace podle Chicago (17th ed.)

Tourbah, Ayman, et al. "MD1003 (high-dose Biotin) for the Treatment of Progressive Multiple Sclerosis: A Randomised, Double-blind, Placebo-controlled Study." Multiple Sclerosis 22, no. 13 (2016): 1719. https://doi.org/10.1177/1352458516667568.

Citace podle MLA (9th ed.)

Tourbah, Ayman, et al. "MD1003 (high-dose Biotin) for the Treatment of Progressive Multiple Sclerosis: A Randomised, Double-blind, Placebo-controlled Study." Multiple Sclerosis, vol. 22, no. 13, 2016, p. 1719, https://doi.org/10.1177/1352458516667568.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..